Genomictree Inc. (228760.KQ)
KRW 23550.0
(3.06%)
KRW 23550.0
(3.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.3 Billion KRW | -819.37% |
| 2022 | 2.4 Billion KRW | 124.41% |
| 2021 | -9.85 Billion KRW | 20.58% |
| 2020 | -12.4 Billion KRW | -20.38% |
| 2019 | -10.3 Billion KRW | -258.04% |
| 2018 | -2.87 Billion KRW | -43.5% |
| 2017 | -2 Billion KRW | -54.96% |
| 2016 | -1.29 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.87 Billion KRW | -29.39% |
| 2024 Q2 | -3.89 Billion KRW | -0.47% |
| 2023 Q1 | -3.64 Billion KRW | 33.16% |
| 2023 Q4 | -2.99 Billion KRW | 17.23% |
| 2023 FY | -17.3 Billion KRW | -819.37% |
| 2023 Q2 | -7.04 Billion KRW | -93.33% |
| 2023 Q3 | -3.62 Billion KRW | 48.62% |
| 2022 Q2 | -3.07 Billion KRW | -121.9% |
| 2022 FY | 2.4 Billion KRW | 124.41% |
| 2022 Q4 | -5.45 Billion KRW | -74.28% |
| 2022 Q3 | -3.12 Billion KRW | -1.59% |
| 2022 Q1 | 14.06 Billion KRW | 768.83% |
| 2021 FY | -9.85 Billion KRW | 20.58% |
| 2021 Q3 | -3.34 Billion KRW | 0.0% |
| 2021 Q4 | -2.1 Billion KRW | 37.21% |
| 2020 FY | -12.4 Billion KRW | -20.38% |
| 2019 FY | -10.3 Billion KRW | -258.04% |
| 2018 FY | -2.87 Billion KRW | -43.5% |
| 2017 FY | -2 Billion KRW | -54.96% |
| 2016 FY | -1.29 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 86.16% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | -426.749% |
| BINEX Co., Ltd. | 1.04 Billion KRW | 1760.184% |
| Bioneer Corporation | 791.75 Million KRW | 2285.466% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | -241.033% |
| MEDIPOST Co., Ltd. | -25.13 Billion KRW | 31.146% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | 44.025% |
| Helixmith Co., Ltd | -35.24 Billion KRW | 50.906% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | -83.588% |
| Medy-Tox Inc. | 17.32 Billion KRW | 199.891% |
| Peptron, Inc. | -15.6 Billion KRW | -10.899% |
| Amicogen, Inc. | 2.05 Billion KRW | 941.552% |
| Genexine, Inc. | -41.24 Billion KRW | 58.043% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | -98.885% |
| LegoChem Biosciences, Inc. | -80.82 Billion KRW | 78.591% |
| ALTEOGEN Inc. | -9.73 Billion KRW | -77.712% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 117.163% |
| SillaJen, Inc. | -21.34 Billion KRW | 18.937% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | 757.018% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | 4.849% |
| MedPacto, Inc. | -28.75 Billion KRW | 39.818% |
| D&D Pharmatech | -13.48 Billion KRW | -28.305% |
| EASY BIO,Inc. | 20.63 Billion KRW | 183.87% |
| GI Innovation, Inc. | -55.6 Billion KRW | 68.881% |